These are the posts from the How we think section that have been tagged with Innovation.
To see all tags used in our posts, click here.
|12th January 2016
Moving into 2016, we want to draw the focus to the issue of tangibly defining value in healthcare innovation and ensuring that the services that pharma and healthcare brands are developing are actually taken up and implemented. Managing Consultant James Atherton talks through some tangible tips for businesses and brands looking to surf the wave of disruption in 2016.
|25th June 2015
The healthcare industry has traditionally been slow to adopt new technologies. This may be due to patient ability or an industry aversion to early adoption, but there is another, often overlooked option available: using existing, established technology to improve patient outcomes through innovative services. Account Executive Will Taylor talks us through a case study in applying established technology to healthcare problems in an innovative way.
|24th June 2015
Director and Head of Commercial Simon takes us through some of the key themes of the Financial Times Digital Health Summit in London, outlining and expanding on where we feel the industry is heading as we get closer to the ‘digital health revolution’.
|16th June 2015
For Blue Latitude Health, the discussion and speculation around the future of the NHS begs the question: what is the role of Pharma in facilitating the deployment of digital transformation? Senior Associate Consultant Angela Lopes has written a thought leadership piece for Blue Latitude Health to tackle this question, based on a piece of research conducted with Consultant David and US VP James from the Strategy team.
|30th March 2015
One of the predictions we made in early 2015 was around wearables: “Wearable tech will play an even more integral role in the collection of aggregated patient data to help identify disease trends, predict treatment outcomes and improve future diagnoses. What we anticipate seeing more of in 2015 is a closer integration between the wearable device and how it feeds information to various sources.”
Account Executive Stuart Goodman takes a look at this prediction and provides an analysis of where wearables are heading.
|12th March 2015
The modern pharmaceutical market can be saturated with competing products, from bio-similars, to same in-class, to alternative MoA treatments. Standing out from the crowd can be tough; innovative and patient serving methods of differentiation are hard to come by.
Consultant Mark Assenti talks through the use of biomarkers in pharma marketing and where it's headed in 2015.
|22nd May 2014
Artificial intelligence (AI) used to be a thing of science-fiction; now it is most definitely a part of our reality. How can a non-human entity help with the advancement of healthcare? In this blog, we explore the recent trends and innovations in AI for healthcare.
|20th March 2014
Paul Midgley is interviewed by Kate from CreatHealth.io about the implementation of NHS Flo, a telehealth tool, in Rushcliffe and his thoughts on whether pharma has a place in supporting and engaging patients and developing healthcare services.